“…Table 2 depicts the reported patients with EOC treated with chemotherapy during pregnancy, including details of maternal and neonatal outcome. Among 69 patients, the most frequent histologic subtypes were serous [1] , [4] , [8] , [30] , [40] , [55] , [56] , [57] , [58] , [59] , [60] , [61] , [62] , [63] , [64] , [65] , mucinous [4] , [8] , [40] , [66] , [67] , [68] , [69] , [70] , [71] and endometrioid [40] , [72] , [73] , [74] in 35, 14 and 4 patients, respectively. These cases have documented the use of combination of taxane and platinum for stage III gestational EOC in both adjuvant and neoadjuvant setting.…”